The proportional decrease in prostate specific antigen level best predicts the duration of survival after hormonal therapy in patients with metastatic carcinoma of the prostate
- 1 September 1996
- journal article
- Published by Wiley in BJU International
- Vol. 78 (3) , 426-431
- https://doi.org/10.1046/j.1464-410x.1996.00079.x
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: